Combination of high throughput and structural screening to assess protein stability - A screening perspective

Eur J Pharm Biopharm. 2022 Feb:171:1-10. doi: 10.1016/j.ejpb.2021.08.018. Epub 2021 Nov 23.

Abstract

High throughput screening for measuring the stability of industrially relevant proteins and their variants is necessary for quality assessment in the development process. Advances in automation, measurement time and sample consumption for many techniques allow rapid measurements with minimal amount of protein. However, many methods include automated data analysis, potentially neglecting important aspects of the protein's behavior in certain conditions. In this study we implement small angle X-ray scattering (SAXS), typically not used to assess protein behavior in industrial screening, in a high throughput screening workflow to address problems of contradicting results and reproducibility among different high throughput methods. As a case study we use the lipases of Thermomyces lanuginosus and Rhizomucor miehei, widely used industrial biocatalysts. We show that even the initial analysis of the SAXS data without performing any time-consuming modelling provide valuable information on interparticle interactions. We conclude that recent advances in automation and data processing, have enabled SAXS to be used more widely as a tool to gain in-depth knowledge highly useful for protein formulation development. This is especially relevant in light of increasing accessibility to SAXS due to the commercial availability of benchtop instruments.

Keywords: Drug screening; High throughput screening; Protein aggregation; Protein engineering; Protein stability; Protein–protein interaction; Small-angle X-ray scattering (SAXS).

MeSH terms

  • High-Throughput Screening Assays
  • Humans
  • Protein Stability*
  • Proteins / chemistry*
  • Reproducibility of Results
  • Scattering, Small Angle
  • X-Ray Diffraction

Substances

  • Proteins